Skip to main content

Peer Review reports

From: Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Original Submission
21 May 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
3 Dec 2015 Editorially accepted
16 Dec 2015 Article published 10.1186/s13063-015-1101-7

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215